• Clinical and Experimental Reproductive Medicine
• /
• v.10 no.1
• /
• pp.7-24
• /
• 1983

On the basis of the semen analysis in 66 subjects, they were divided into six different groups: Group I consisted of 16 normal subjects with sperm counts of over 40 ${\times}10^6$/ml and motility of over 40 percent, Group II, 7 subjects with normal sperm counts, but motility of under 40 percent, Group III, 15 oligospermic patients with under 40 ${\times}10^6$/ml, Group IV 14 azoospermic patients, Group V, 10 patients with vasectomy and Group VI, 4 abnormal patients with 2 cases of hypoplastic testis, 1 case of Klinefelter's syndrome and 1 case of testis tumor. After seperation of semen into sperm and seminal plasma by centrifugation, the protein contents and the activities of hyaluronidase, ${\beta}$-N acetylglucosaminidase, ${\beta}$-glucuronidase, arylsulfatase, acrosin and azocoll proteinase in seminal plasma were measured. Vasectomy group has 30 percent less of total protein than normal group. For the comparison of enzyme activities of seminal plasma, it could be assumed that the enzymes in seminal plasma were not contaminated with the enzymes of spermatozoa by testing the enzymes of the seminal plasma from the vasectomy and azoospermic groups. It had been reported that hyaluronidase was only released from spermatozoa, however, the result obtained in this investigation showed that azoospermic and vasectomy group had high specific activities of hyaluronidase. The results indicated that hyaluronidase was not only from the testis but also from the male accessory sexual glands. Oligospermic group (Group III) showed the lowest total activity of hyaluronidase among them. The specific activities of ${\beta}$ -N-acetylglucosaminidase was high in oligospermic group (Group III) and low in vasectomy group (Group V). These results were contradictory with the pattern of hyaluronidase activities. This indicated that the spermatozoa which were stayed in epididymis would increase the activity of this enzyme. The specific activity of ${\beta}$ - glucuronidase was low in oligospermic and vasectomy groups. Group VI including testis tumor had remarkably high arylsulfatase activity. Arylsulfatase, a typical lysosomal enzyme, has been known to be released unusually large amounts from certain tumor cells. Arylsulfatase was also released with high activities from azoospermic and vascetomy group. This result indicated that this enzyme was also released from the sources other than testis. Acrosin, a proteolytic enzyme locating in the sperm acrosome, was not found throughout all the samples of seminal plasma. The activities of azocoll proteinase, a non-specific neutral proteinase was nearly identical in all the groups. This enzyme must have been released from the sources other than testis.

• Proceedings of the Korean Society of Life Science Conference
• /
• 2006.09a
• /
• pp.102.2-102.2
• /
• 2006

• Proceedings of the Korean Society of Life Science Conference
• /
• 2003.10a
• /
• pp.102-102
• /
• 2003

• Journal of Wetlands Research
• /
• v.14 no.1
• /
• pp.47-57
• /
• 2012

We have measured soil enzyme activities, which represent the rates of organic matter decomposition, in four riparian ecosystems in Korea. ${\beta}$-glucosidase, N-acetylglucosaminidase, phosphatase and arylsulfatase activities were determined in five occasions over a year period in soils of control plots and plots with invasive plants, namely Sicyos angulatus and Humulus japonicus. Significantly higher enzyme activities were found in soils with invasive plant in barren land, but the difference was season and enzyme-specific. Although it was not universal changes, the invasive plants appeared to accelerate organic matter decomposition in some disturbed riparian ecosystems.

• Journal of The Korean Society of Inherited Metabolic disease
• /
• v.16 no.1
• /
• pp.24-33
• /
• 2016

Mucopolysaccharidosis type VI (MPS VI) is a rare disease caused by the mutation of ARSB with prevalence range from 1/5,000 in northeast Brazil to 1/2,057,529 births in Czech Republic. In Asia, there is only one published figure in Taiwan of about 1/833,000 births. The exact prevalence in the Korean population is unknown, but we estimated the incidence of MPS VI is about 0.03/100,000 live births. Enzyme replacement therapy (ERT) with recombinant human Arylsulfatase B (rhASB) is a modality for the treatment of MPS VI that reduces the excretion of urine glycosaminoglycan (GAG) and improves joint motion, pulmonary function, and endurance. We presented the clinical features, molecular analysis and outcome of ERT in three Korean MPS VI patients. All patients had the typical characteristic clinical features of MPS IV. Short stature, dysostosis multiplex, corneal opacity and valvular heart disease were found at first presentation, while restrictive lung disease and carpal tunnel syndrome developed later in all patients. Molecular analysis demonstrated novel missense and nonsense mutation in the patients, including p.Ile 67Ser, p.Gly328Arg, $p.Arg191^*$, p.Asp352Asn, and p.Gly17Asp. After ERT, urine GAG was decreased in all patients. Skeletal involvement, corneal opacity, heart valve abnormalities and pulmonary function were not improved with ERT, but it had a better outcome on regarding joint motion and endurance. One patient underwent allogeneic bone marrow transplantation (BMT) prior to ERT, but their clinical response was not improved much after BMT. This study demonstrates clinical phenotypes and molecular analysis of the severe form of MPS VI in Korean patients.

• Journal of Microbiology and Biotechnology
• /
• v.25 no.11
• /
• pp.1894-1901
• /
• 2015

A novel sulfatase gene, ary423 (1,536 bp ORF), encoding a protein of 511 amino acids with a calculated molecular mass of 56 kDa, was identified from Flammeovirga pacifica, which was isolated from deep-sea sediments of west Pacific Ocean. Amino acid sequence analysis revealed that Ary423 possessed a conserved C-X-A-X-R motif, which was recognized as the sulfatase signature. Phylogenetic analysis suggested that Ary423 belonged to arylsulfatases. After heterologous expression in Escherichia coli cells, the recombinant Ary423 was purified with a Ni⁺ affinity column, and was shown to be highly active at a broad range of temperatures from 30° to 70℃, with maximum activity at 40℃. Furthermore, recombinant Ary423 retained more than 70% and 40% of its maximum activity after 12 h of incubation at 50℃ and 60℃, respectively, exhibiting good thermostability at high temperatures. The optimal pH for Ary423 was determined to be 8.0 and the activity of Ary423 could be slightly enhanced by Mg²⁺. The recombinant enzyme could hydrolyze sulfate ester bonds in p-nitrophenyl sulfate (NPS) and Asparagus crude polysaccharides with a specific activity of 64.8 U/mg and 25.4 U/mg, respectively. These favorable properties could make Ary423 attractive for application in the desulfating process of agar production.

• Journal of Genetic Medicine
• /
• v.19 no.1
• /
• pp.32-37
• /
• 2022

Mucopolysaccharidosis type VI (MPS VI) is an autosomal recessive lysosomal disorder caused by the deficiency of arylsulfatase B due to mutations in the ARSB gene. Here, we report the case of a Korean female with a novel variant of MPS VI. A Korean female aged 5 years and 8 months, who is the only child of a healthy non-consanguineous Korean couple, presented at our hospital for severe short stature. She had a medical history of umbilical hernia and recurrent otitis media. Her symptoms included snoring and mouth breathing. Subtle dysmorphic features, including mild coarse face, joint contracture, hepatomegaly, and limited range of joint motion, were identified. Radiography revealed deformities, suggesting skeletal dysplasia. Growth hormone (GH) provocation tests revealed complete GH deficiency. Targeted exome sequencing revealed compound heterozygous mutations in the ARSB genes c.512G>A (p.Gly171Asp; a pathogenic variant inherited from her father) and c.1157C>T (p.Ser386Phe; a novel variant inherited from her mother in familial genetic testing). Quantitative tests revealed increased urine glycosaminoglycan (GAG) levels and decreased enzyme activity of arylsulfatase B. While on enzyme replacement therapy and GH therapy, her height increased drastically; her coarse face, joint contracture, snoring, and obstructive sleep apnea improved; urine GAG decreased; and left ventricular mass index was remarkably decreased. We report a novel variant-c.1157C>T (p.Ser386Phe)-of the ARSB gene in a patient with MPS VI; these findings will expand our knowledge of its clinical spectrum and molecular mechanisms.

• Proceedings of the Korean Society of Soil and Groundwater Environment Conference
• /
• 2004.09a
• /
• pp.211-214
• /
• 2004

MTBE로 오염된 토양에서 생태독성학적 접근 방법으로 3가지 토양 효소의 활성도를 측정해 보았다. MTBE의 잠재적 위험성으로 인한 논란은 계속되고 있으나 토양 오염에 대한 지표로써 토양 효소 활성도의 사용타당성 여부에 대한 실험은 이전에 행해지지 않았다. 따라서 중금속 오염 토양에 대해 좋은 지표로 사용되고 있는 토양 미생물 효소의 활성도를 MTBE에 적용하여 실험해 보았다. 사용한 토양 효소는 Acid Phosphotase, $\beta$-Glucosidase 그리고 Arysulfatase였다. 그러나 실험 결과 MTBE로 오염된 토양의 경우 중금속으로 오염된 토양에 비해 토양 미생물 활성도의 감소가 매우 적었다. 따라서 MTBE의 오염 토양의 경우 본 연구에서 측정된 효소의 활성도는 좋은 지표로 적합하지 않다는 것을 확인했다.

• Environmental Engineering Research
• /
• v.22 no.2
• /
• pp.224-229
• /
• 2017

Zinc oxide nanoparticles (ZnO NPs) have been used as additives in a variety of consumer products. While these particles may enter the environment, only a limited number of studies have investigated the effects of ZnO NPs on soil exoenzymes. Here, we investigate the long-term effects of ZnO NPs at concentrations of 50 and 500 mg/kg on the activities of six soil exoenzymes in planted soils: Dehydrogenase, fluorescein diacetate (FDA) hydrolase, urease, acid phosphatase, arylsulfatase, and ${\beta}-glucosidase$. Significant effects were observed at one or more time points for all enzymes except for FDA hydrolase. These effects included both decreases and increases in enzyme activity. Our results suggest that ZnO NP treatments of 50 and 500 mg/kg can adversely affect soil enzymes, particularly acid phosphatase and urease, and thus, these data may have implications for phosphorous and nitrogen cycles in the soil.

• Clinical and Experimental Reproductive Medicine
• /
• v.8 no.2
• /
• pp.25-28
• /
• 1981

정자의 아크로좀에 존재한다고 알려진 효소들중 실온에 방치할 경우 또는 완충용액으로 정자를 세척할 경우 쉽게 아크로좀 막으로부터 흘러나옴을 관찰하였다. 신선하게 사용된 토끼의 정액을 $0^{\circ}C$에서 트리스 완충용액에 방치할 경우 하이얄유로니데이스는 39%정도가 유출되어 나오고, 또 $37^{\circ}C$에서 1시간 더 둘 경우 나머지 30%, 그리고 두시간째에 17%가 방출되며, 계면활성제로 아크롬을 처리할 경우 단 4%의 효소가 추출되었다. 다른 두 탄수화물 분해요소인 베타 엔 애시틸글루코사미니데이스 및 베타 그룩유로니데이스도 하이얄유로니데이스처럼 쉽게 분리되어 나오고 계면활성제로 추출될 수 있는 양은 대단히 적었다. 이와같이 효소가 아크로좀에서 방출되는 정도에 따라 아크로좀막에 흡착된 정도를 알 수 있으며 동시에 수정과정에서 역활을 이해하는데 도움이 될 것이다.